A detailed history of Bridgefront Capital, LLC transactions in Sanofi stock. As of the latest transaction made, Bridgefront Capital, LLC holds 6,210 shares of SNY stock, worth $321,553. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,210
Previous 16,933 63.33%
Holding current value
$321,553
Previous $818,000 64.18%
% of portfolio
0.09%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$45.07 - $51.35 $483,285 - $550,626
-10,723 Reduced 63.33%
6,210 $293,000
Q2 2025

Aug 14, 2025

BUY
$47.62 - $55.44 $557,344 - $648,869
11,704 Added 223.83%
16,933 $818,000
Q1 2025

May 15, 2025

BUY
$48.15 - $59.42 $251,776 - $310,707
5,229 New
5,229 $290,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $130B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.